** Shares of health insurer Humana HUM.N rise 5% to $244.5 premarket
** Co forecasts 2025 adj EPS to be ~$17 vs its previous estimate of ~$16.25
** Insurers have been grappling with persistently high costs due to increased use of healthcare services across government-backed health plans
** HUM reports Q2 medical cost ratio - the percentage of premiums spent on medical care - of 89.7% in line with analysts' estimates of 89.71%, according to data compiled by LSEG
** HUM posts Q2 adj EPS of $6.27, above analysts' estimate of $5.92
** Up to last close, stock down over 8% YTD
(Reporting by Mariam Sunny in Bengaluru)
((Mariam.ESunny@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.